hydrochlorothiazide has been researched along with nilvadipine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Fritschka, E | 1 |
| Belz, GG; Breithaupt-Grögler, K; Meurer-Witt, B; Ungethüm, W | 1 |
2 trial(s) available for hydrochlorothiazide and nilvadipine
| Article | Year |
|---|---|
Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Triamterene | 1992 |
Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Bisoprolol; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Hydrochlorothiazide; Imidazoles; Imidazolidines; Male; Nifedipine; Sodium Chloride Symporter Inhibitors | 2001 |
1 other study(ies) available for hydrochlorothiazide and nilvadipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |